HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Communication Aids for Disabled (TDD)

Subscribe to New Research on Communication Aids for Disabled

Equipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.

Also Known As:

TDD; Speech Synthesizers; Communication Board; Speech Synthesizer; Telecommunications Devices for the Deaf; TTY Telephone; Text Telecommunication; Text Telecommunication Devices; Text Telephone; Synthesizer, Speech; Synthesizers, Speech; TTY Telephones; Telecommunication Device, Text; Telecommunication Devices, Text; Telecommunication, Text; Telecommunications, Text; Text Telecommunication Device; Text Telecommunications; Text Telephones; Augmentative and Alternative Communications Systems; Communication Aids for Handicapped; Communication Boards

Networked: 50 relevant articles (5 outcomes, 6 trials/studies) for this Therapy, Comments

Relationship Network

Therapy Context: Research Results

Equipment and Supplies
- Self-Help Devices: 310
  - Communication Aids for Disabled: 50

Experts

1.	Olausson, H W: 1 article (05/2010)
2.	Lundblad, L C: 1 article (05/2010)
3.	Löken, L S: 1 article (05/2010)
4.	Löken, Linda S: 1 article (05/2010)
5.	King, Allen B: 1 article (05/2010)
6.	Elam, M: 1 article (05/2010)
7.	Noh, Yun-Hee: 1 article (04/2010)
8.	Martínez-Quiñones, J V: 1 article (04/2010)
9.	Lim, Inja: 1 article (04/2010)
10.	Lee, Won-Jin: 1 article (04/2010)

Related Diseases

1.	Respiratory Insufficiency (Respiratory Failure) 01/01/1989 - "We have prospectively assessed the efficacy of TDD in improving pulmonary gas exchange in 12 patients with severe acute pancreatitis (SAP) complicated by persistent respiratory failure despite standard conservative treatment including peritoneal dialysis in 8 patients. " 12/01/1999 - "STUDY OBJECTIVES: To establish the value of electrical impedance tomography (EIT) in assessing pulmonary edema in noncardiogenic acute respiratory failure (ARF), as compared to the thermal dye double indicator dilution technique (TDD). " Order ALL the reference details at left...
2.	Neoplasms (Cancer) 12/01/2003 - "Therefore, a new form of TDD, 4-hexadecyl-TDD (HDD), was developed to improve tumor retention by introducing a long alkyl chain. " 07/01/2000 - "The kinetic features of skin tumors with ductal differentiation (TDD) remain mainly unknown. " 12/01/2003 - "CONCLUSION: Introduction of a long alkyl chain significantly improved the tumor retention of (188)Re-HDD/lipiodol, compared with that of (188)Re-TDD/lipiodol. " 07/01/2000 - "PR and MFC are useful malignancy criteria in skin TDD and should be evaluated by tumor cellularity to avoid potential misinterpretations related with tumor heterogeneity." 12/01/2003 - "In this study, we compared the tumor retention properties of (188)Re-HDD/lipiodol and (188)Re-TDD/lipiodol, using a rabbit liver cancer model, and performed dosimetry using the results. " Order ALL the reference details at left...
3.	Rheumatoid Arthritis 12/01/1984 - "Thoracic duct drainage (TDD) led to major improvement of disease in two of five patients with severe rheumatoid arthritis and lesser improvement in two others. " 06/01/1984 - "Five patients with rheumatoid arthritis (RA), who were treated by lymphocyte depletion by using thoracic duct drainage (TDD), provided an opportunity to characterize the phenotype and function of their recirculating lymphocytes. " 12/01/1979 - "Thoracic duct drainage (TDD) was performed in 4 patients with severe rheumatoid arthritis. " 12/01/1991 - "Lymphocytapheresis using thoracic duct drainage (TDD) is a recognized technique of extracorporeal immunomodulation for various autoimmune diseases such as rheumatoid arthritis (RA), and its clinical benefit has been reported and generally accepted. " Order ALL the reference details at left...
4.	Pain (Aches) 11/01/2006 - "Further research is needed to test the effects of a communication board and other methods of facilitating communication on outcomes such as satisfaction and anxiety of patients, adequate and appropriate management of pain, and length of mechanical ventilation time and hospital stay." 04/01/2010 - "MATERIALS AND METHODS: We conducted an observational, prospective study, over a group of 858 patients, with the following inclusion criteria: 1. MRI imaging indicating TDD, 2. No signs or symptoms requiring urgent surgical treatment (cauda equina syndrome, progressive or serious motor deficit or unbearable pain) and 3. Development of progressively spontaneous symptoms remission. " Order ALL the reference details at left...
5.	Hypoglycemia (Reactive Hypoglycemia) 01/01/2009 - "Mean BG values in two 24 h experiments were approximately 142 and approximately 155 mg/dl, with the total daily dose (TDD) of insulin being approximately 0.8-1.0 U per kilogram of body mass and the TDD of glucagon being approximately 0.02-0.05 mg. Results also affirmed the efficacy of SC doses of glucagon in staving off episodic hypoglycemia. " 10/01/2006 - "Total daily insulin dose (TDD), body mass index (BMI), glycosylated hemoglobin (HbA(1c)), and frequency of hypoglycemia in the preceding 3 months were assessed at recruitment, third month and sixth month. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Iodized Oil (Lipiodol)
2.	Insulin (Novolin)
3.	Glucagon (Glukagon)
4.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
5.	Tacrine (Cognex)
6.	Thiamine (Aneurin)
7.	basal insulin
8.	Direction compound
9.	Steroids
10.	Pyrithiamine

Related Therapies and Procedures

1.	Peritoneal Dialysis
2.	Immunomodulation
3.	Transplants (Transplant)
4.	Speech Therapy (Therapy, Speech)
5.	Artificial Respiration (Mechanical Ventilation)

blog comments powered by Disqus

TREATMENT OPTIONS
for Respiratory Insufficiency,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 497 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>